Bähr R, Ammann R, Bircher J, Eckert J
Chirurg. 1984 Feb;55(2):114-6.
In human echinococcosis, today as in the past, surgical removal of the parasite remains the treatment of choice. Beside certain conditions, adjuvant chemotherapy with Vermox is indicated for echinococcus multilocularis as well as echinococcus granulosus. A substantial decrease of the echinococcal parasite mass under Mebendazole is not yet known. Nevertheless jaundiced patients with diffuse liver infestation with echinococcus multilocularis became jaundice-free and able to work. Mebendazole toleration is very good. A closely interrelated medical control of patients under Mebendazole therapy ought to be interdisciplinarily carried through between internists and surgeons.
在人类棘球蚴病中，如今和过去一样，手术切除寄生虫仍然是首选的治疗方法。除某些情况外，对于多房棘球绦虫以及细粒棘球绦虫，使用甲苯达唑进行辅助化疗是有必要的。目前尚不清楚甲苯达唑能否使棘球绦虫的虫体大量减少。然而，患有多房棘球绦虫弥漫性肝脏感染的黄疸患者黄疸消退且能够工作。甲苯达唑的耐受性非常好。对于接受甲苯达唑治疗的患者，内科医生和外科医生应进行跨学科的密切医学监测。
